QuantHealth raises $45M Series B to expand AI clinical trial simulation QuantHealth has raised $45 million in a Series B funding round led by Qumra Capital to expand its AI-driven clinical trial simulation platform and accelerate adoption of simulation-fi... See more
Circio advances circular RNA gene therapy platform towards clinical development Circio is preparing to advance its circular RNA gene therapy platform towards clinical development after raising approximately NOK 620 million ($65 million) in new funding dur... See more
Jascayd approval expands treatment options for pulmonary fibrosis in Europe Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, expanding treatment options for ... See more
National Health Council launches Detroit campaign to address kidney screening gap The National Health Council has launched a Detroit pilot campaign aimed at increasing awareness of urine albumin-to-creatinine ratio testing among people at high risk of chr... See more
Enzene launches local biomanufacturing model to cut biologics manufacturing costs Enzene has launched a biomanufacturing model designed to help governments and biopharma companies establish local facilities for producing biologic medicines. Enzene launche... See more
